This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) shed 2.28% to $120.40 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&amp;P 500 Index  falling 1.07% to 6,827.41 and Dow Jones Industrial Average  falling 0.51% to 48,458.05.
The stock's fall snapped a two-day winning streak.
Gilead Sciences Inc. closed 6.45% short of its 52-week high of $128.70, which the company achieved on November 20th.
The stock underperformed when compared to some of its competitors Friday, as Johnson &amp; Johnson (JNJ) rose 0.75% to $211.58, Pfizer Inc. (PFE) rose 0.19% to $25.85, and Abbott Laboratories (ABT) rose 1.77% to $125.46.
Trading volume (6.7 M) remained 493,722 below its 50-day average volume of 7.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 12, 2025.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-12-25 1635ET

GILD

<p>Gilead Sciences Inc. stock fell 2.28% to $120.40 on Friday, underperforming compared to competitors like Johnson & Johnson, Pfizer, and Abbott Laboratories, which saw gains. The stock closed 6.45% short of its 52-week high, with trading volume below its 50-day average. The S&P 500 and Dow Jones also declined.</p>

Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors